Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.
http://dlvr.it/SQm7h4

Yorumlar

Bu blogdaki popüler yayınlar

PSİKOLOJİDE PROBLEME ODAKLANMAK VE DÖNGÜ

QUOTATİON İN PSYCHOLOGY